Analysen von Jeffrey Holford
| 19.03.14 | Bayer buy | Jefferies & Company Inc. | |
| 19.03.14 | Sanofi buy | Jefferies & Company Inc. | |
| 19.03.14 | GSK Hold | Jefferies & Company Inc. | |
| 19.03.14 | Novartis Hold | Jefferies & Company Inc. | |
| 07.03.14 | Bayer buy | Jefferies & Company Inc. | |
| 14.11.12 | Pfizer buy | Jefferies & Company Inc. | |
| 13.11.12 | Johnson Johnson hold | Jefferies & Company Inc. | |
| 16.10.12 | Pfizer buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 15.10.12 | Eli Lilly underperform | Jefferies & Company Inc. | |
| 14.08.12 | Merck hold | Jefferies & Company Inc. | |
| 13.08.12 | Pfizer buy | Jefferies & Company Inc. | |
| 16.07.12 | Pfizer buy | Jefferies & Company Inc. | |
| 24.04.12 | Pfizer buy | Jefferies & Company Inc. | |
| 20.03.12 | Pfizer buy | Jefferies & Company Inc. | |
| 11.01.12 | Merck hold | Jefferies & Company Inc. | |
| 10.01.12 | Eli Lilly hold | Jefferies & Company Inc. | |
| 10.08.11 | Merck buy | Jefferies & Company Inc. | |
| 05.08.10 | Eli Lilly hold | Jefferies & Company Inc. | |
| 30.06.10 | AstraZeneca halten | Jefferies & Company Inc. | |